Small Cell Lung Cancer: Advancing Precision Medicine with Biomarker Research
Precision medicine is an innovative approach to disease prevention and treatment that considers differences in... read more
December 4, 2024
Tagged: lung cancer
Dr. Blagosklonny’s Strategy: From Osimertinib to Preemptive Combinations
This article dissects Dr. Mikhail V. Blagosklonny’s paradigm-shifting perspective on preemptive combinations for treating... read more
June 6, 2024
The Obesity Paradox, Metformin and Lung Cancer
In a new editorial, researchers from Instituto Nacional de Cancerología discuss the "obesity paradox"... read more
July 27, 2023
New Target Fights Ferroptosis- and Radio-Resistance in Lung Cancers
Researchers published a research perspective about a recent study that uncovered FSP1 as a novel... read more
November 2, 2022
Trending With Impact: Analysis of Mutational Burden in NSCLC
Researchers conducted a multi-site cohort study of tumor mutational burden among hundreds of patients diagnosed... read more
April 21, 2022
New Study: ALK Rearrangement Among Lung Cancer Patients
In Oncotarget’s Volume 12, Issue 23, cover paper, researchers retrospectively assessed the prevalence of... read more
November 10, 2021
Trending With Impact: Unconventional Method Effectively Targets NSCLC
In a trending paper published by Oncotarget, researchers developed a divergent strategy to treat non-small... read more
September 30, 2021
Trending With Impact: Promising Non-Small Cell Lung Cancer Prodrug
Researchers examined the preclinical prodrug LP-184 and its efficacy in treating non-small cell lung cancers... read more
August 26, 2021
Behind the Study: Retaining Nanomolar Potency in Lung Cancer
Dr. Aditya Kulkarni discusses a study he co-authored, published by Oncotarget in 2021, and entitled, “... read more
August 16, 2021
Behind the Study: miRNA-185 Emerges as Regulator of KRAS
Harvard Medical School Professor Frank Slack discusses his 2016 study published in Oncotarget, entitled, “Cis-acting... read more
April 18, 2021